Saturday, January 18, 2025
spot_img

Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1 Details of the person discharging managerial responsibilities (PDMR)/person closely associated with them (PCA)
a) Name Michael Brierley
2 Reason for the notification
a) Position/status Non-Executive Director/PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Admiral Group plc
b) LEI 213800FGVM7Z9EJB2685
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

GB00B02J6398

b) Nature of the transaction Acquisition of 21 shares pursuant to a dividend reinvestment trading plan entered into on 17 May 2020.
c)

Prices(s) and volume(s)

Price(s) Volume(s)
£27.35
£27.36

4
17

d) Aggregated information

  • Aggregated volume
  • Price

21

£27.36

e) Date of the transaction 14 October 2024
f) Place of the transaction London Stock Exchange (XLON)

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1 Details of the person discharging managerial responsibilities (PDMR)/person closely associated with them (PCA)
a) Name Rachel Brierley
2 Reason for the notification
a) Position/status Wife of Non-Executive Director/PDMR, Michael Brierley/PCA
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Admiral Group plc
b) LEI 213800FGVM7Z9EJB2685
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

GB00B02J6398

b) Nature of the transaction Acquisition of 91 shares pursuant to a dividend reinvestment trading plan entered into on 17 May 2020.
c)

Prices(s) and volume(s)

Price(s) Volume(s)
£27.36 91
d) Aggregated information

  • Aggregated value
  • Price
N/A (Single Transaction)
e) Date of the transaction 14 October 2024
f) Place of the transaction London Stock Exchange (XLON)

Powered by SlickText.com

Hot this week

ThreeD Capital Inc. Completes Private Placement Financing

TORONTO, Jan. 17, 2025 (GLOBE NEWSWIRE) --...

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Transdermal GFR System (TGFR) is a first-in-kind product for...

Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering

LITTLE ROCK, Ark., Jan. 17, 2025 (GLOBE...

Corporate Update

MONTREAL, Jan. 17, 2025 (GLOBE NEWSWIRE) --...

Lifecore Biomedical Announces Special Stockholder Meeting

Company Seeking to Remove Convertible Preferred Stock Exchange Cap...

Topics

ThreeD Capital Inc. Completes Private Placement Financing

TORONTO, Jan. 17, 2025 (GLOBE NEWSWIRE) --...

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Transdermal GFR System (TGFR) is a first-in-kind product for...

Corporate Update

MONTREAL, Jan. 17, 2025 (GLOBE NEWSWIRE) --...

Lifecore Biomedical Announces Special Stockholder Meeting

Company Seeking to Remove Convertible Preferred Stock Exchange Cap...

XORTX Announces Change of Auditor

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img